Lamotriginevdispersible Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets(IR & ER)

Available Strengths: XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Reference Brands: Lamictal, Lamictal XR(EU & US)

Category: Multiple sclerosis

LamotriginevDispersible tablets is available in Tablets(IR & ER) and strengths such as XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, LamotriginevDispersible tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

LamotriginevDispersible tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Lamotrigine dispersible tablets, available as immediate-release (IR) and extended-release (ER), are approved in the US by the FDA and in the EU via EMA for epilepsy and bipolar disorder management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial data and manufacturing processes, while the EMA ensures compliance with regional safety and quality regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance facilitates timely approvals, supports safe use, and promotes worldwide availability of lamotrigine dispersible tablets, improving long-term patient care globally.